Literature DB >> 10330418

What happens to deltaF508 in vivo?

M Drumm1.   

Abstract

Mesh：

Substances：

Year:  1999        PMID： 10330418      PMCID： PMC408460          DOI： 10.1172/JCI7119

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  9 in total

1.  Altered chloride ion channel kinetics associated with the delta F508 cystic fibrosis mutation.

Authors:  W Dalemans; P Barbry; G Champigny; S Jallat; K Dott; D Dreyer; R G Crystal; A Pavirani; J P Lecocq; M Lazdunski
Journal:  Nature       Date:  1991 Dec 19-26       Impact factor: 49.962

2.  DeltaF508 CFTR protein expression in tissues from patients with cystic fibrosis.

Authors:  N Kälin; A Claass; M Sommer; E Puchelle; B Tümmler
Journal:  J Clin Invest       Date:  1999-05-15       Impact factor: 14.808

3.  In vivo activation of the cystic fibrosis transmembrane conductance regulator mutant deltaF508 in murine nasal epithelium.

Authors:  T J Kelley; K Thomas; L J Milgram; M L Drumm
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

Review 4.  Cystic fibrosis: genotypic and phenotypic variations.

Authors:  J Zielenski; L C Tsui
Journal:  Annu Rev Genet       Date:  1995       Impact factor: 16.830

5.  The in vivo effects of milrinone on the airways of cystic fibrosis mice and human subjects.

Authors:  S N Smith; P G Middleton; S Chadwick; A Jaffe; K A Bush; S Rolleston; R Farley; S J Delaney; B Wainwright; D M Geddes; E W Alton
Journal:  Am J Respir Cell Mol Biol       Date:  1999-01       Impact factor: 6.914

6.  Mislocalization of delta F508 CFTR in cystic fibrosis sweat gland.

Authors:  N Kartner; O Augustinas; T J Jensen; A L Naismith; J R Riordan
Journal:  Nat Genet       Date:  1992-08       Impact factor: 38.330

Review 7.  The spectrum of cystic fibrosis mutations.

Authors:  L C Tsui
Journal:  Trends Genet       Date:  1992-11       Impact factor: 11.639

8.  Submucosal glands are the predominant site of CFTR expression in the human bronchus.

Authors:  J F Engelhardt; J R Yankaskas; S A Ernst; Y Yang; C R Marino; R C Boucher; J A Cohn; J M Wilson
Journal:  Nat Genet       Date:  1992-11       Impact factor: 38.330

9.  The cystic fibrosis mutation (delta F508) does not influence the chloride channel activity of CFTR.

Authors:  C Li; M Ramjeesingh; E Reyes; T Jensen; X Chang; J M Rommens; C E Bear
Journal:  Nat Genet       Date:  1993-04       Impact factor: 38.330
  9 in total
  3 in total

Review 1.  Protein processing and inflammatory signaling in Cystic Fibrosis: challenges and therapeutic strategies.

Authors:  C N Belcher; N Vij
Journal:  Curr Mol Med       Date:  2010-02       Impact factor: 2.222

2.  VX-809 mitigates disease in a mouse model of autosomal dominant polycystic kidney disease bearing the R3277C human mutation.

Authors:  Murali K Yanda; Liudmila Cebotaru
Journal:  FASEB J       Date:  2021-11       Impact factor: 5.834

3.  Role of oxygen availability in CFTR expression and function.

Authors:  Jennifer S Guimbellot; James A Fortenberry; Gene P Siegal; Bryan Moore; Hui Wen; Charles Venglarik; Yiu-Fai Chen; Suzanne Oparil; Eric J Sorscher; Jeong S Hong
Journal:  Am J Respir Cell Mol Biol       Date:  2008-05-12       Impact factor: 6.914
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.